Medinol Revenue and Competitors

Medinol is dedicated to the science of cardiovascular intervention. For over 25 years, we have delivered over two million coronary stents to patients worldwide. Our products constantly stretch the limits of innovation and our cutting-edge technology continues to demonstrate extraordinary clinical results. We make our products in-house using proprietary manufacturing technologies that ensure consistently exceptional quality and safety. Medinol manufactures EluNIR™, the first elastomeric drug eluting stent. Now FDA approved and CE marked, EluNIR demonstrated excellent clinical outcomes and promising safety profile in two clinical studies and features the Flexx² catheter technology with a metallic spring-tip, resulting in unprecedented ease-of-delivery even in tough anatomies. A unique stent design provides low metal footprint and optimized vessel support, leveraged by an elastomeric coating that ensures excellent surface quality. Founded in 1992 by Dr. Judith Richter and Dr. Kobi Richter and privately held to this day, Medinol continues to benefit from the leadership and insight of its founders. With more than 300 employees on board, we proudly maintain our family spirit and entrepreneurial culture. Interested in joining Medinol ? Click the link below to visit our website